BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ubukata H, Motohashi G, Tabuchi T, Nagata H, Konishi S, Tabuchi T. Evaluations of interferon-γ/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients. J Surg Oncol. 2010;102:742-747. [PMID: 20872813 DOI: 10.1002/jso.21725] [Cited by in Crossref: 104] [Cited by in F6Publishing: 111] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Y, Bai Y, Shen M, Li Y. Therapeutic strategies for gastric cancer targeting immune cells: Future directions. Front Immunol 2022;13:992762. [DOI: 10.3389/fimmu.2022.992762] [Reference Citation Analysis]
2 Zhao Z, Yin XN, Wang J, Chen X, Cai ZL, Zhang B. Prognostic significance of hemoglobin, albumin, lymphocyte, platelet in gastrointestinal stromal tumors: A propensity matched retrospective cohort study. World J Gastroenterol 2022; 28(27): 3476-3487 [DOI: 10.3748/wjg.v28.i27.3476] [Reference Citation Analysis]
3 Kotecha K, Singla A, Townend P, Merrett N. Association between neutrophil-lymphocyte ratio and lymph node metastasis in gastric cancer: A meta-analysis. Medicine (Baltimore) 2022;101:e29300. [PMID: 35758361 DOI: 10.1097/MD.0000000000029300] [Reference Citation Analysis]
4 Jaroenlapnopparat A, Bhatia K, Coban S. Inflammation and Gastric Cancer. Diseases 2022;10:35. [DOI: 10.3390/diseases10030035] [Reference Citation Analysis]
5 Shijubou N, Sumi T, Yamada Y, Nakata H, Mori Y, Chiba H. Immunological and nutritional predictive factors in patients receiving pembrolizumab for the first-line treatment of non-small cell lung cancer. J Cancer Res Clin Oncol. [DOI: 10.1007/s00432-022-03941-2] [Reference Citation Analysis]
6 Yan B, Xiong J, Ye Q, Xue T, Xiang J, Xu M, Li F, Wen W. Correlation and prognostic implications of intratumor and tumor draining lymph node Foxp3+ T regulatory cells in colorectal cancer. BMC Gastroenterol 2022;22:122. [PMID: 35296257 DOI: 10.1186/s12876-022-02205-0] [Reference Citation Analysis]
7 Qin H, Lu Y, Du L, Shi J, Yin H, Jiang B, Chen W, Diao W, Ding M, Cao W, Qiu X, Zhao X, Guo H. Pan-cancer analysis identifies LMNB1 as a target to redress Th1/Th2 imbalance and enhance PARP inhibitor response in human cancers. Cancer Cell Int 2022;22:101. [PMID: 35241075 DOI: 10.1186/s12935-022-02467-4] [Reference Citation Analysis]
8 Bai Z, Zhou Y, Ye Z, Xiong J, Lan H, Wang F. Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy. Front Immunol 2021;12:808964. [PMID: 35095898 DOI: 10.3389/fimmu.2021.808964] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
9 Mahhengam N, Kazemnezhad K, Setia Budi H, Ansari MJ, Olegovich Bokov D, Suksatan W, Thangavelu L, Siahmansouri H. Targeted therapy of tumor microenvironment by gold nanoparticles as a new therapeutic approach. Journal of Drug Targeting. [DOI: 10.1080/1061186x.2022.2032095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Weadick CS, Duffy AG, Kelly RJ. Recent advances in immune-based approaches for the treatment of esophagogastric cancer. Expert Opin Emerg Drugs 2022;:1-13. [PMID: 34937483 DOI: 10.1080/14728214.2021.2020757] [Reference Citation Analysis]
11 Haider N, Mahmood Z, Khalid F, Razzak SA. Neutrophils to lymphocytes ratio between benign and malignant thyroid nodule. Pak J Med Sci 2021;37:1908-11. [PMID: 34912416 DOI: 10.12669/pjms.37.7.4503] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Yang E, Chua W, Ng W, Roberts TL. Peripheral Cytokine Levels as a Prognostic Indicator in Gastric Cancer: A Review of Existing Literature. Biomedicines 2021;9:1916. [PMID: 34944729 DOI: 10.3390/biomedicines9121916] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Bao L, Sun K, Zhang X. PANX1 is a potential prognostic biomarker associated with immune infiltration in pancreatic adenocarcinoma: A pan-cancer analysis. Channels (Austin) 2021;15:680-96. [PMID: 34796785 DOI: 10.1080/19336950.2021.2004758] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Zhu Y, Zhang C, Zhao D, Li W, Zhao Z, Yao S, Zhao D. BDNF Acts as a Prognostic Factor Associated with Tumor-Infiltrating Th2 Cells in Pancreatic Adenocarcinoma. Dis Markers 2021;2021:7842035. [PMID: 34777634 DOI: 10.1155/2021/7842035] [Reference Citation Analysis]
15 Koc G, Soyocak A, Duzgun Ergun D, Pastaci Ozsobaci N, Andac-Ozturk S, Ergun S. Association of TRPM5 Asn235Ser Polymorphism and Trace Elements/Minerals in Chronic Gastritis Patients: a Case-Control Study. Biol Trace Elem Res 2021. [PMID: 34767145 DOI: 10.1007/s12011-021-03002-8] [Reference Citation Analysis]
16 Wang D, Cabalag CS, Clemons NJ, DuBois RN. Cyclooxygenases and Prostaglandins in Tumor Immunology and Microenvironment of Gastrointestinal Cancer. Gastroenterology 2021;161:1813-29. [PMID: 34606846 DOI: 10.1053/j.gastro.2021.09.059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
17 Wang DK, Zuo Q, He QY, Li B. Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications. Front Immunol 2021;12:705999. [PMID: 34447376 DOI: 10.3389/fimmu.2021.705999] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
18 Feng M, Feng Q, Chen Y, Liu G, Gao Z, Xiao J, Feng C. Effect of Dezocine on the Ratio of Th1/Th2 Cytokines in Patients Receiving Postoperative Analgesia Following Laparoscopic Radical Gastrectomy: A Prospective Randomised Study. Drug Des Devel Ther 2021;15:2289-97. [PMID: 34079227 DOI: 10.2147/DDDT.S306120] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Yoneda A, Kuroki T, Eguchi S. Immunotherapeutic advances in gastric cancer. Surg Today 2021. [PMID: 33590326 DOI: 10.1007/s00595-021-02236-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
20 Senovilla L, Vacchelli E, Galon J, Adjemian S, Eggermont A, Fridman WH, Sautès-Fridman C, Ma Y, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Prognostic and predictive value of the immune infiltrate in cancer. Oncoimmunology 2012;1:1323-43. [PMID: 23243596 DOI: 10.4161/onci.22009] [Cited by in Crossref: 160] [Cited by in F6Publishing: 159] [Article Influence: 160.0] [Reference Citation Analysis]
21 Ogura Y, Kataoka N, Kunimatsu Y, Tachibana Y, Sugimoto T, Tani N, Sato I, Hirose K, Kato D, Takeda T. Predictors of survival among Japanese patients receiving first-line chemoimmunotherapy for advanced non-small cell lung cancer. Thorac Cancer 2021;12:97-105. [PMID: 33124197 DOI: 10.1111/1759-7714.13720] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
22 Li Q, Huang LY, Xue HP. Comparison of prognostic factors in different age groups and prognostic significance of neutrophil-lymphocyte ratio in patients with gastric cancer. World J Gastrointest Oncol 2020; 12(10): 1146-1166 [PMID: 33133383 DOI: 10.4251/wjgo.v12.i10.1146] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Fan X, Jin J, Yan L, Liu L, Li Q, Xu Y. The impaired anti-tumoral effect of immune surveillance cells in the immune microenvironment of gastric cancer. Clinical Immunology 2020;219:108551. [DOI: 10.1016/j.clim.2020.108551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
24 Zeng H, Ji J, Song X, Huang Y, Li H, Huang J, Ma X. Stemness Related Genes Revealed by Network Analysis Associated With Tumor Immune Microenvironment and the Clinical Outcome in Lung Adenocarcinoma. Front Genet 2020;11:549213. [PMID: 33193623 DOI: 10.3389/fgene.2020.549213] [Cited by in Crossref: 3] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
25 Chen T, Guo J, Cai Z, Li B, Sun L, Shen Y, Wang S, Wang Z, Wang Z, Wang Y, Zhou H, Cai Z, Ye Z. Th9 Cell Differentiation and Its Dual Effects in Tumor Development. Front Immunol 2020;11:1026. [PMID: 32508847 DOI: 10.3389/fimmu.2020.01026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
26 Li Y, Wang HC, Wang JS, Sun B, Li LP. Chemokine receptor 4 expression is correlated with the occurrence and prognosis of gastric cancer. FEBS Open Bio 2020;10:1149-61. [PMID: 32306562 DOI: 10.1002/2211-5463.12864] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
27 Maeda S, Nakazawa M, Uchida M, Yoshitake R, Nakagawa T, Nishimura R, Miyamoto R, Bonkobara M, Yonezawa T, Momoi Y. Foxp3+ Regulatory T Cells Associated With CCL17/CCR4 Expression in Carcinomas of Dogs. Vet Pathol 2020;57:497-506. [PMID: 32347186 DOI: 10.1177/0300985820921535] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
28 Baj J, Brzozowska K, Forma A, Maani A, Sitarz E, Portincasa P. Immunological Aspects of the Tumor Microenvironment and Epithelial-Mesenchymal Transition in Gastric Carcinogenesis. Int J Mol Sci 2020;21:E2544. [PMID: 32268527 DOI: 10.3390/ijms21072544] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
29 Hu J, Yu J, Gan J, Song N, Shi L, Liu J, Zhang Z, Du J. Notch1/2/3/4 are prognostic biomarker and correlated with immune infiltrates in gastric cancer. Aging (Albany NY) 2020;12:2595-609. [PMID: 32028262 DOI: 10.18632/aging.102764] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
30 Huang Z, Wu L, Hou Z, Zhang P, Li G, Xie J. Eosinophils and other peripheral blood biomarkers in glioma grading: a preliminary study. BMC Neurol 2019;19:313. [PMID: 31805879 DOI: 10.1186/s12883-019-1549-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
31 Zheng HL, Lu J, Xie JW, Wang JB, Lin JX, Chen QY, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Li P, Zheng CH, Huang CM. Exploring the value of new preoperative inflammation prognostic score: white blood cell to hemoglobin for gastric adenocarcinoma patients. BMC Cancer 2019;19:1127. [PMID: 31752770 DOI: 10.1186/s12885-019-6213-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
32 Alečković M, McAllister SS, Polyak K. Metastasis as a systemic disease: molecular insights and clinical implications. Biochim Biophys Acta Rev Cancer 2019;1872:89-102. [PMID: 31202687 DOI: 10.1016/j.bbcan.2019.06.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 5.7] [Reference Citation Analysis]
33 Shin SJ, Kim SY, Choi YY, Son T, Cheong JH, Hyung WJ, Noh SH, Park CG, Kim HI. Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response.Oncologist. 2019;24:e835-e844. [PMID: 30894409 DOI: 10.1634/theoncologist.2018-0273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
34 Ajeigbe KO, Emikpe BO, Olaleye SB. Effects of artemisinin, with or without lumefantrine and amodiaquine on gastric ulcer healing in rat. J Basic Clin Physiol Pharmacol 2018;29:515-24. [PMID: 29702486 DOI: 10.1515/jbcpp-2017-0145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
35 Hou M, Zhou N, Li H, Wang B, Wang X, Wang X, Jiang T, Wang K, Xue F. Morphine and ketamine treatment suppress the differentiation of T helper cells of patients with colorectal cancer in vitro. Exp Ther Med 2019;17:935-42. [PMID: 30651883 DOI: 10.3892/etm.2018.7035] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Sun L, Chen L, Li H. Checkpoint-modulating immunotherapies in tumor treatment: Targets, drugs, and mechanisms. Int Immunopharmacol 2019;67:160-75. [PMID: 30553199 DOI: 10.1016/j.intimp.2018.12.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
37 Chraa D, Naim A, Olive D, Badou A. T lymphocyte subsets in cancer immunity: Friends or foes. J Leukoc Biol 2018;105:243-55. [DOI: 10.1002/jlb.mr0318-097r] [Cited by in Crossref: 46] [Cited by in F6Publishing: 59] [Article Influence: 11.5] [Reference Citation Analysis]
38 Gonzalez H, Hagerling C, Werb Z. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev. 2018;32:1267-1284. [PMID: 30275043 DOI: 10.1101/gad.314617.118] [Cited by in Crossref: 419] [Cited by in F6Publishing: 630] [Article Influence: 104.8] [Reference Citation Analysis]
39 Choi JH, Suh YS, Choi Y, Han J, Kim TH, Park SH, Kong SH, Lee HJ, Yang HK. Comprehensive Analysis of the Neutrophil-to-Lymphocyte Ratio for Preoperative Prognostic Prediction Nomogram in Gastric Cancer. World J Surg. 2018;42:2530-2541. [PMID: 29392430 DOI: 10.1007/s00268-018-4510-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
40 Ohno Y. Role of systemic inflammatory response markers in urological malignancy. Int J Urol 2019;26:31-47. [PMID: 30253448 DOI: 10.1111/iju.13801] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
41 Ganguli P, Sarkar RR. Exploring immuno-regulatory mechanisms in the tumor microenvironment: Model and design of protocols for cancer remission. PLoS One 2018;13:e0203030. [PMID: 30183728 DOI: 10.1371/journal.pone.0203030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
42 Lazăr DC, Avram MF, Romoșan I, Cornianu M, Tăban S, Goldiș A. Prognostic significance of tumor immune microenvironment and immunotherapy: Novel insights and future perspectives in gastric cancer. World J Gastroenterol 2018; 24(32): 3583-3616 [PMID: 30166856 DOI: 10.3748/wjg.v24.i32.3583] [Cited by in CrossRef: 77] [Cited by in F6Publishing: 77] [Article Influence: 19.3] [Reference Citation Analysis]
43 Takeda T, Takeuchi M, Saitoh M, Takeda S. Neutrophil-to-lymphocyte ratio after four weeks of nivolumab administration as a predictive marker in patients with pretreated non-small-cell lung cancer. Thorac Cancer 2018;9:1291-9. [PMID: 30126063 DOI: 10.1111/1759-7714.12838] [Cited by in Crossref: 25] [Cited by in F6Publishing: 33] [Article Influence: 6.3] [Reference Citation Analysis]
44 Wang D, DuBois RN. Role of prostanoids in gastrointestinal cancer. J Clin Invest 2018;128:2732-42. [PMID: 29733297 DOI: 10.1172/JCI97953] [Cited by in Crossref: 48] [Cited by in F6Publishing: 60] [Article Influence: 12.0] [Reference Citation Analysis]
45 Sylman JL, Mitrugno A, Atallah M, Tormoen GW, Shatzel JJ, Tassi Yunga S, Wagner TH, Leppert JT, Mallick P, McCarty OJT. The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis. Front Oncol 2018;8:78. [PMID: 29619344 DOI: 10.3389/fonc.2018.00078] [Cited by in Crossref: 25] [Cited by in F6Publishing: 35] [Article Influence: 6.3] [Reference Citation Analysis]
46 Bowen RC, Little NAB, Harmer JR, Ma J, Mirabelli LG, Roller KD, Breivik AM, Signor E, Miller AB, Khong HT. Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis. Oncotarget 2017;8:32171-89. [PMID: 28418870 DOI: 10.18632/oncotarget.16291] [Cited by in Crossref: 37] [Cited by in F6Publishing: 53] [Article Influence: 9.3] [Reference Citation Analysis]
47 Wei M, Shen D, Mulmi Shrestha S, Liu J, Zhang J, Yin Y. The Progress of T Cell Immunity Related to Prognosis in Gastric Cancer. Biomed Res Int 2018;2018:3201940. [PMID: 29682534 DOI: 10.1155/2018/3201940] [Cited by in Crossref: 10] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
48 Kelly RJ. Immunotherapy for Esophageal and Gastric Cancer. Am Soc Clin Oncol Educ Book 2017;37:292-300. [PMID: 28561677 DOI: 10.1200/EDBK_175231] [Cited by in Crossref: 6] [Cited by in F6Publishing: 35] [Article Influence: 1.2] [Reference Citation Analysis]
49 Dolan RD, Lim J, McSorley ST, Horgan PG, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis. Sci Rep. 2017;7:16717. [PMID: 29196718 DOI: 10.1038/s41598-017-16955-5] [Cited by in Crossref: 112] [Cited by in F6Publishing: 149] [Article Influence: 22.4] [Reference Citation Analysis]
50 Verbiest A, Couchy G, Job S, Zucman-Rossi J, Caruana L, Lerut E, Oyen R, de Reyniès A, Laguerre B, Rioux-Leclercq N, Wozniak A, Joniau S, Van Poppel H, Van Den Eynde K, Beuselinck B. Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated With Outcome During Pazopanib Therapy in the Metastatic Setting. Clin Genitourin Cancer 2018;16:e605-12. [PMID: 29239846 DOI: 10.1016/j.clgc.2017.10.017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
51 Tahara T, Tahara S, Horiguchi N, Kawamura T, Okubo M, Yamada H, Yoshida D, Ohmori T, Maeda K, Komura N, Ikuno H, Jodai Y, Kamano T, Nagasaka M, Nakagawa Y, Tsukamoto T, Urano M, Shibata T, Kuroda M, Ohmiya N. Methylation status of IGF2 DMR and LINE1 in leukocyte DNA provides distinct clinicopathological features of gastric cancer patients. Clin Exp Med 2018;18:215-20. [DOI: 10.1007/s10238-017-0471-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
52 Ikeguchi M, Hanaki T, Endo K, Suzuki K, Nakamura S, Sawata T, Shimizu T. C-Reactive Protein/Albumin Ratio and Prognostic Nutritional Index Are Strong Prognostic Indicators of Survival in Resected Pancreatic Ductal Adenocarcinoma. Journal of Pancreatic Cancer 2017;3:31-6. [DOI: 10.1089/crpc.2017.0006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
53 Nayak A, McDowell DT, Kellie SJ, Karpelowsky J. Elevated Preoperative Neutrophil-Lymphocyte Ratio is Predictive of a Poorer Prognosis for Pediatric Patients with Solid Tumors. Ann Surg Oncol 2017;24:3456-62. [PMID: 28718035 DOI: 10.1245/s10434-017-6006-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
54 Kang BW, Kim JG, Lee IH, Bae HI, Seo AN. Clinical significance of tumor-infiltrating lymphocytes for gastric cancer in the era of immunology. World J Gastrointest Oncol 2017; 9(7): 293-299 [PMID: 28808502 DOI: 10.4251/wjgo.v9.i7.293] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
55 Ikeguchi M, Hanaki T, Endo K, Suzuki K, Nakamura S, Sawata T, Shimizu T. C-Reactive Protein/Albumin Ratio and Prognostic Nutritional Index Are Strong Prognostic Indicators of Survival in Resected Pancreatic Ductal Adenocarcinoma. J Pancreat Cancer 2017;3:31-6. [PMID: 30631838 DOI: 10.1089/pancan.2017.0006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
56 Jensen-Jarolim E, Bax HJ, Bianchini R, Capron M, Corrigan C, Castells M, Dombrowicz D, Daniels-Wells TR, Fazekas J, Fiebiger E, Gatault S, Gould HJ, Janda J, Josephs DH, Karagiannis P, Levi-Schaffer F, Meshcheryakova A, Mechtcheriakova D, Mekori Y, Mungenast F, Nigro EA, Penichet ML, Redegeld F, Saul L, Singer J, Spicer JF, Siccardi AG, Spillner E, Turner MC, Untersmayr E, Vangelista L, Karagiannis SN. AllergoOncology - the impact of allergy in oncology: EAACI position paper. Allergy 2017;72:866-87. [PMID: 28032353 DOI: 10.1111/all.13119] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 10.2] [Reference Citation Analysis]
57 Li SH, Wang QX, Yang ZY, Jiang W, Li C, Sun P, Wei W, Shi M, Guo RP. Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis. World J Gastroenterol 2017; 23(17): 3122-3132 [PMID: 28533669 DOI: 10.3748/wjg.v23.i17.3122] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
58 Thompson ED, Zahurak M, Murphy A, Cornish T, Cuka N, Abdelfatah E, Yang S, Duncan M, Ahuja N, Taube JM, Anders RA, Kelly RJ. Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma. Gut 2017;66:794-801. [PMID: 26801886 DOI: 10.1136/gutjnl-2015-310839] [Cited by in Crossref: 246] [Cited by in F6Publishing: 258] [Article Influence: 49.2] [Reference Citation Analysis]
59 Jung SW, Park IJ, Oh SH, Yeom SS, Lee JL, Yoon YS, Kim CW, Lim SB, Lee JB, Yu CS, Kim JC. Association of immunologic markers from complete blood counts with the response to preoperative chemoradiotherapy and prognosis in locally advanced rectal cancer. Oncotarget 2017;8:59757-65. [PMID: 28938679 DOI: 10.18632/oncotarget.15760] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
60 Zhou X, Xu L, Huang Z, Zhang L, Zhang H, Zhu W, Liu P. The hematologic markers as prognostic factors in patients with resectable gastric cancer. Cancer Biomark 2016;17:359-67. [PMID: 27434296 DOI: 10.3233/CBM-160648] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
61 Pang W, Lou N, Jin C, Hu C, Arvine C, Zhu G, Shen X. Combination of preoperative platelet/lymphocyte and neutrophil/lymphocyte rates and tumor-related factors to predict lymph node metastasis in patients with gastric cancer. Eur J Gastroenterol Hepatol 2016;28:493-502. [PMID: 26854795 DOI: 10.1097/MEG.0000000000000563] [Cited by in Crossref: 13] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
62 Mao M, Qian Y, Sun J. Morphine Suppresses T helper Lymphocyte Differentiation to Th1 Type Through PI3K/AKT Pathway. Inflammation 2016;39:813-21. [PMID: 26883517 DOI: 10.1007/s10753-016-0310-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
63 Toiyama Y, Yasuda H, Ohi M, Yoshiyama S, Araki T, Tanaka K, Inoue Y, Mohri Y, Kusunoki M. Clinical impact of preoperative albumin to globulin ratio in gastric cancer patients with curative intent. The American Journal of Surgery 2017;213:120-6. [DOI: 10.1016/j.amjsurg.2016.05.012] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 6.4] [Reference Citation Analysis]
64 Zhao Q, Xu X, Yue J, Zhu K, Feng R, Jiang S, Qi Z, Wang R. Minimum absolute lymphocyte counts during radiation are associated with a worse prognosis in patients with unresectable hepatocellular carcinoma. Therap Adv Gastroenterol 2017;10:231-41. [PMID: 28203281 DOI: 10.1177/1756283X16685557] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
65 Ikeguchi M, Kouno Y, Kihara K, Suzuki K, Endo K, Nakamura S, Sawada T, Shimizu T, Matsunaga T, Fukumoto Y, Saito H. Evaluation of prognostic markers for patients with curatively resected thoracic esophageal squamous cell carcinomas. Mol Clin Oncol 2016;5:767-72. [PMID: 28105355 DOI: 10.3892/mco.2016.1073] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
66 Ma HY, Liu XZ, Liang CM. Inflammatory microenvironment contributes to epithelial-mesenchymal transition in gastric cancer. World J Gastroenterol 2016; 22(29): 6619-6628 [PMID: 27547005 DOI: 10.3748/wjg.v22.i29.6619] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
67 Chen Y, Chen K, Xiao X, Nie Y, Qu S, Gong C, Su F, Song E. Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study. BMC Cancer. 2016;16:320. [PMID: 27198767 DOI: 10.1186/s12885-016-2352-8] [Cited by in Crossref: 62] [Cited by in F6Publishing: 89] [Article Influence: 10.3] [Reference Citation Analysis]
68 Wang T, Tian L, Gao M, Song H, Wei Y, Xue Y. Interleukin (IL)-4 -590C& gt; T polymorphism is not associated with the susceptibility of gastric cancer: An updated meta-analysis. Ann Med Surg (Lond). 2016;9:1-5. [PMID: 27284401 DOI: 10.1016/j.amsu.2016.05.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
69 Wang SC, Chou JF, Strong VE, Brennan MF, Capanu M, Coit DG. Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma. Ann Surg. 2016;263:292-297. [PMID: 25915915 DOI: 10.1097/sla.0000000000001189] [Cited by in Crossref: 81] [Cited by in F6Publishing: 97] [Article Influence: 13.5] [Reference Citation Analysis]
70 Xia WK, Liu ZL, Shen D, Lin QF, Su J, Mao WD. Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma. World J Surg Oncol 2016;14:127. [PMID: 27125872 DOI: 10.1186/s12957-016-0889-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 46] [Article Influence: 5.2] [Reference Citation Analysis]
71 Kirilovsky A, Marliot F, El Sissy C, Haicheur N, Galon J, Pagès F. Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients. Int Immunol 2016;28:373-82. [PMID: 27121213 DOI: 10.1093/intimm/dxw021] [Cited by in Crossref: 93] [Cited by in F6Publishing: 101] [Article Influence: 15.5] [Reference Citation Analysis]
72 Takaki H, Imai N, Contessa TT, Srimathveeravalli G, Covey AM, Getrajdman GI, Brown KT, Solomon SB, Erinjeri JP. Peripheral Blood Regulatory T-Cell and Type 1 Helper T-Cell Population Decrease after Hepatic Artery Embolization. J Vasc Interv Radiol 2016;27:1561-8. [PMID: 27084711 DOI: 10.1016/j.jvir.2016.01.150] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
73 Spiegel A, Brooks MW, Houshyar S, Reinhardt F, Ardolino M, Fessler E, Chen MB, Krall JA, DeCock J, Zervantonakis IK, Iannello A, Iwamoto Y, Cortez-Retamozo V, Kamm RD, Pittet MJ, Raulet DH, Weinberg RA. Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells. Cancer Discov 2016;6:630-49. [PMID: 27072748 DOI: 10.1158/2159-8290.CD-15-1157] [Cited by in Crossref: 194] [Cited by in F6Publishing: 246] [Article Influence: 32.3] [Reference Citation Analysis]
74 Sun J, Chen X, Gao P, Song Y, Huang X, Yang Y, Zhao J, Ma B, Gao X, Wang Z. Can the Neutrophil to Lymphocyte Ratio Be Used to Determine Gastric Cancer Treatment Outcomes? A Systematic Review and Meta-Analysis. Dis Markers 2016;2016:7862469. [PMID: 26924872 DOI: 10.1155/2016/7862469] [Cited by in Crossref: 32] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
75 Teng JJ, Zhang J, Zhang TY, Zhang S, Li BS. Prognostic value of peripheral blood lymphocyte-to-monocyte ratio in patients with solid tumors: a meta-analysis. Onco Targets Ther 2016;9:37-47. [PMID: 26730202 DOI: 10.2147/OTT.S94458] [Cited by in Crossref: 7] [Cited by in F6Publishing: 26] [Article Influence: 1.0] [Reference Citation Analysis]
76 Ling A, Lundberg IV, Eklöf V, Wikberg ML, Öberg Å, Edin S, Palmqvist R. The infiltration, and prognostic importance, of Th1 lymphocytes vary in molecular subgroups of colorectal cancer. J Pathol Clin Res 2016;2:21-31. [PMID: 27499912 DOI: 10.1002/cjp2.31] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
77 Liu T, Fang XC, Ding Z, Sun ZG, Sun LM, Wang YL. Pre-operative lymphocyte-to-monocyte ratio as a predictor of overall survival in patients suffering from osteosarcoma. FEBS Open Bio. 2015;5:682-687. [PMID: 26380812 DOI: 10.1016/j.fob.2015.08.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
78 Teng MW, Galon J, Fridman WH, Smyth MJ. From mice to humans: developments in cancer immunoediting. J Clin Invest 2015;125:3338-46. [PMID: 26241053 DOI: 10.1172/JCI80004] [Cited by in Crossref: 157] [Cited by in F6Publishing: 157] [Article Influence: 22.4] [Reference Citation Analysis]
79 Xin-Ji Z, Yong-Gang L, Xiao-Jun S, Xiao-Wu C, Dong Z, Da-Jian Z. The prognostic role of neutrophils to lymphocytes ratio and platelet count in gastric cancer: A meta-analysis. Int J Surg 2015;21:84-91. [PMID: 26225826 DOI: 10.1016/j.ijsu.2015.07.681] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 7.6] [Reference Citation Analysis]
80 Hu ZD, Huang YL, Qin BD, Tang QQ, Yang M, Ma N, Fu HT, Wei TT, Zhong RQ. Prognostic value of neutrophil to lymphocyte ratio for gastric cancer. Ann Transl Med 2015;3:50. [PMID: 25861605 DOI: 10.3978/j.issn.2305-5839.2015.03.26] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
81 Ozyalvacli ME, Ozyalvacli G, Kocaaslan R, Cecen K, Uyeturk U, Kemahlı E, Gucuk A. Neutrophil-lymphocyte ratio as a predictor of recurrence and progression in patients with high-grade pT1 bladder cancer. Can Urol Assoc J 2015;9:E126-31. [PMID: 25844098 DOI: 10.5489/cuaj.2523] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
82 Deng Q, He B, Liu X, Yue J, Ying H, Pan Y, Sun H, Chen J, Wang F, Gao T, Zhang L, Wang S. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model. J Transl Med. 2015;13:66. [PMID: 25885254 DOI: 10.1186/s12967-015-0409-0] [Cited by in Crossref: 100] [Cited by in F6Publishing: 130] [Article Influence: 14.3] [Reference Citation Analysis]
83 Ural ÜM, Şehitoğlu İ, Tekin YB, Şahin FK. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in patients with endometrial hyperplasia and endometrial cancer. J Obstet Gynaecol Res 2015;41:445-8. [PMID: 25363740 DOI: 10.1111/jog.12536] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
84 Ramirez MF, Ai D, Bauer M, Vauthey JN, Gottumukkala V, Kee S, Shon D, Truty M, Kuerer HM, Kurz A, Hernandez M, Cata JP. Innate immune function after breast, lung, and colorectal cancer surgery. J Surg Res 2015;194:185-93. [PMID: 25475022 DOI: 10.1016/j.jss.2014.10.030] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
85 Yilmaz H, Bozkurt A, Cakmak M, Celik HT, Bilgic MA, Bavbek N, Akcay A. Relationship between late arteriovenous fistula (AVF) stenosis and neutrophil–lymphocyte ratio (NLR) in chronic hemodialysis patients. Renal Failure 2014;36:1390-4. [DOI: 10.3109/0886022x.2014.945183] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
86 Ikeguchi M, Urushibara S, Shimoda R, Yamamoto M, Maeta Y, Ashida K. Inflammation-based prognostic scores and nutritional prognostic index in patients with locally-advanced unresectable colorectal cancer. World J Surg Oncol. 2014;12:210. [PMID: 25022764 DOI: 10.1186/1477-7819-12-210] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
87 Young CA, Murray LJ, Karakaya E, Thygesen HH, Sen M, Prestwich RJ. The Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Oropharyngeal Carcinoma Treated with Chemoradiotherapy. Clin Med Insights Oncol 2014;8:81-6. [PMID: 25057245 DOI: 10.4137/CMO.S15476] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
88 Sionov RV, Fridlender ZG, Granot Z. The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment. Cancer Microenviron. 2014; Jun 4. [Epub ahead of print]. [PMID: 24895166 DOI: 10.1007/s12307-014-0147-5] [Cited by in Crossref: 172] [Cited by in F6Publishing: 220] [Article Influence: 21.5] [Reference Citation Analysis]
89 Chang WJ, Du Y, Zhao X, Ma LY, Cao GW. Inflammation-related factors predicting prognosis of gastric cancer. World J Gastroenterol 2014; 20(16): 4586-4596 [PMID: 24782611 DOI: 10.3748/wjg.v20.i16.4586] [Cited by in CrossRef: 119] [Cited by in F6Publishing: 118] [Article Influence: 14.9] [Reference Citation Analysis]
90 Paramanathan A, Saxena A, Morris DL. A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours. Surgical Oncology 2014;23:31-9. [DOI: 10.1016/j.suronc.2013.12.001] [Cited by in Crossref: 176] [Cited by in F6Publishing: 196] [Article Influence: 22.0] [Reference Citation Analysis]
91 Cho IR, Park JC, Park CH, Jo JH, Lee HJ, Kim S, Shim CN, Lee H, Shin SK, Lee SK, Lee YC. Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer. Gastric Cancer. 2014;17:703-710. [PMID: 24442663 DOI: 10.1007/s10120-013-0330-2] [Cited by in Crossref: 65] [Cited by in F6Publishing: 77] [Article Influence: 8.1] [Reference Citation Analysis]
92 Kim JY, Park T, Jeong SH, Jeong CY, Ju YT, Lee YJ, Hong SC, Ha WS, Choi SK, Jung EJ. Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas. Endocrine 2014;46:526-31. [PMID: 24272600 DOI: 10.1007/s12020-013-0089-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 4.0] [Reference Citation Analysis]
93 Kim JY, Park T, Jeong SH, Jeong CY, Ju YT, Lee YJ, Hong SC, Ha WS, Choi SK, Jung EJ. Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas. Endocrine 2014;46:526-31. [PMID: 24272600 DOI: 10.1007/s12020-013-0089-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
94 Mano Y, Shirabe K, Yamashita Y, Harimoto N, Tsujita E, Takeishi K, Aishima S, Ikegami T, Yoshizumi T, Yamanaka T. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg. 2013;258:301-305. [PMID: 23774313 DOI: 10.1097/sla.0b013e318297ad6b] [Cited by in Crossref: 190] [Cited by in F6Publishing: 219] [Article Influence: 21.1] [Reference Citation Analysis]
95 Linton A, van Zandwijk N, Reid G, Clarke S, Cao C, Kao S. Inflammation in malignant mesothelioma - friend or foe? Ann Cardiothorac Surg 2012;1:516-22. [PMID: 23977546 DOI: 10.3978/j.issn.2225-319X.2012.10.02] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
96 Wörmann SM, Diakopoulos KN, Lesina M, Algül H. The immune network in pancreatic cancer development and progression. Oncogene 2014;33:2956-67. [PMID: 23851493 DOI: 10.1038/onc.2013.257] [Cited by in Crossref: 106] [Cited by in F6Publishing: 120] [Article Influence: 11.8] [Reference Citation Analysis]
97 Linton A, Pond G, Clarke S, Vardy J, Galsky M, Sonpavde G. Glasgow prognostic score as a prognostic factor in metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy. Clin Genitourin Cancer 2013;11:423-30. [PMID: 23816526 DOI: 10.1016/j.clgc.2013.04.020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
98 Hong CC, Yao S, McCann SE, Dolnick RY, Wallace PK, Gong Z, Quan L, Lee KP, Evans SS, Repasky EA, Edge SB, Ambrosone CB. Pretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers. Breast Cancer Res Treat 2013;139:477-88. [PMID: 23624818 DOI: 10.1007/s10549-013-2549-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
99 Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88:218-230. [PMID: 23602134 DOI: 10.1016/j.critrevonc.2013.03.010] [Cited by in Crossref: 645] [Cited by in F6Publishing: 765] [Article Influence: 71.7] [Reference Citation Analysis]
100 Seretis C, Gourgiotis S, Gemenetzis G, Seretis F, Lagoudianakis E, Dimitrakopoulos G. The significance of neutrophil/lymphocyte ratio as a possible marker of underlying papillary microcarcinomas in thyroidal goiters: a pilot study. Am J Surg 2013;205:691-6. [PMID: 23388425 DOI: 10.1016/j.amjsurg.2012.08.006] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 6.2] [Reference Citation Analysis]
101 Ohno Y, Nakashima J, Ohori M, Tanaka A, Hashimoto T, Gondo T, Hatano T, Tachibana M. Clinical variables for predicting metastatic renal cell carcinoma patients who might not benefit from cytoreductive nephrectomy: neutrophil-to-lymphocyte ratio and performance status. Int J Clin Oncol 2014;19:139-45. [DOI: 10.1007/s10147-012-0514-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
102 Wang J, Shan A, Liu T, Zhang C, Zhang Z. In vitro immunomodulatory effects of an oleanolic acid-enriched extract of Ligustrum lucidum fruit (Ligustrum lucidum supercritical CO2 extract) on piglet immunocytes. Int Immunopharmacol 2012;14:758-63. [PMID: 23099145 DOI: 10.1016/j.intimp.2012.10.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
103 Gao M, Sun J, Jin W, Qian Y. Morphine, but not ketamine, decreases the ratio of Th1/Th2 in CD4-positive cells through T-bet and GATA3. Inflammation 2012;35:1069-77. [PMID: 22160839 DOI: 10.1007/s10753-011-9413-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
104 Fridman WH, Pagès F, Sautès-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12:298-306. [PMID: 22419253 DOI: 10.1038/nrc3245] [Cited by in Crossref: 2376] [Cited by in F6Publishing: 2538] [Article Influence: 237.6] [Reference Citation Analysis]
105 Jutzy JM, Khan S, Asuncion-Valenzuela MM, Milford TA, Payne KJ, Wall NR. Tumor-released survivin induces a type-2 t cell response and decreases cytotoxic T cell function, in vitro. Cancer Microenviron 2013;6:57-68. [PMID: 22322461 DOI: 10.1007/s12307-012-0096-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
106 Ohno Y, Nakashima J, Ohori M, Gondo T, Hatano T, Tachibana M. Followup of neutrophil-to-lymphocyte ratio and recurrence of clear cell renal cell carcinoma. J Urol. 2012;187:411-417. [PMID: 22177153 DOI: 10.1016/j.juro.2011.10.026] [Cited by in Crossref: 77] [Cited by in F6Publishing: 87] [Article Influence: 7.0] [Reference Citation Analysis]
107 Kosmaczewska A, Bocko D, Ciszak L, Wlodarska-Polinska I, Kornafel J, Szteblich A, Masternak A, Frydecka I. Dysregulated expression of both the costimulatory CD28 and inhibitory CTLA-4 molecules in PB T cells of advanced cervical cancer patients suggests systemic immunosuppression related to disease progression. Pathol Oncol Res. 2012;18:479-489. [PMID: 22094905 DOI: 10.1007/s12253-011-9471-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
108 Gao M, Jin W, Qian Y, Ji L, Feng G, Sun J. Effect of N-methyl-D-aspartate receptor antagonist on T helper cell differentiation induced by phorbol-myristate-acetate and ionomycin. Cytokine 2011;56:458-65. [DOI: 10.1016/j.cyto.2011.06.022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
109 Wang GY, Yang Y, Li H, Zhang J, Jiang N, Li MR, Zhu HB, Zhang Q, Chen GH. A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantation. PLoS One 2011;6:e25295. [PMID: 21966488 DOI: 10.1371/journal.pone.0025295] [Cited by in Crossref: 56] [Cited by in F6Publishing: 67] [Article Influence: 5.1] [Reference Citation Analysis]
110 Aizawa M, Gotohda N, Takahashi S, Konishi M, Kinoshita T. Predictive Value of Baseline Neutrophil/Lymphocyte Ratio for T4 Disease in Wall-Penetrating Gastric Cancer. World J Surg 2011;35:2717-22. [DOI: 10.1007/s00268-011-1269-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
111 Clarke SJ, Chua W, Moore M, Kao S, Phan V, Tan C, Charles K, Mcmillan DC. Use of Inflammatory Markers to Guide Cancer Treatment. Clin Pharmacol Ther 2011;90:475-8. [DOI: 10.1038/clpt.2011.122] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]